• Zoom In
  • Search
  • Search
 

Notice of 2019 Annual Meeting and Proxy Statement

Time and Date
9:00 a.m., Eastern Daylight Time (EDT), on Thursday, April 25, 2019

Place
Hilton Short Hills Hotel, 41 John F. Kennedy Parkway, Short Hills, New Jersey 07078, +1-973-379-0100

Record Date
You can vote your shares if you were a shareholder of record at the close of business on February 26, 2019.

Audio Webcast
Available at www.pfizer.com, starting at 9:00 a.m., EDT, on Thursday, April 25, 2019. A replay will be available through May 31, 2019.

ITEMS OF BUSINESS

  • To elect 11 members of the Board of Directors, each until our next Annual Meeting and/or until his or her successor has been duly elected and qualified.
  • To ratify the selection of KPMG LLP as our independent registered public accounting firm for the 2019 fiscal year.
  • To conduct an advisory vote to approve our executive compensation.
  • To approve the Pfizer Inc. 2019 Stock Plan.
  • To consider 4 shareholder proposals, if properly presented at the Meeting.
  • To transact any other business that properly comes before the Meeting and any adjournment or postponement of the Meeting.

VOTING YOUR SHARES IS QUICK AND EASY—YOU CAN EVEN VOTE USING YOUR SMARTPHONE OR TABLET.

HOW TO VOTE

For registered holders and Pfizer Savings Plan participants:
(Shares are registered in your name with Pfizer's transfer agent, Computershare, or held in the Pfizer Savings Plan)
For beneficial owners:
(Shares are held in a stock brokerage account or by a bank or other holder of record)
Internet
Internet*
www.investorvote.com/PFE www.proxyvote.com
Telephone
Telephone*
Within the U.S., U.S. territories & Canada
+1-800-652-VOTE (8683) – toll-free
Outside of the U.S., U.S. territories & Canada
+1-781-575-2300 – standard rates apply
+1-800-454-VOTE (8683) – toll-free

Mail
Mail
Complete, sign and return the proxy card Complete, sign and return the voting instruction card
* You will need to provide your control number that appears on the right-hand side of the enclosed proxy card or voting instruction card.

HOW TO VOTE

For registered holders and Pfizer Savings Plan participants:
(Shares are registered in your name with Pfizer's transfer agent, Computershare, or held in the Pfizer Savings Plan)


Internet
Internet*
www.investorvote.com/PFE


Telephone
Telephone*
Within the U.S., U.S. territories & Canada
+1-800-652-VOTE (8683) – toll-free

Outside of the U.S., U.S. territories & Canada
+1-781-575-2300 – standard rates apply


Mail
Mail
Complete, sign and return the proxy card

HOW TO VOTE

For beneficial owners:
(Shares are held in a stock brokerage account or by a bank or other holder of record)


Internet
Internet*
www.proxyvote.com


Telephone
Telephone*
+1-800-454-VOTE (8683) – toll-free


Mail
Mail
Complete, sign and return the voting instruction card

* You will need to provide your control number that appears on the right-hand side of the enclosed proxy card or voting instruction card.

MATERIALS TO REVIEW

This booklet contains our Notice of 2019 Annual Meeting and Proxy Statement. Our 2018 Financial Report is included as Appendix A and is followed by certain Corporate and Shareholder Information. None of Appendix A, the Corporate and Shareholder Information, or the accompanying Letter from our Executive Chairman and Chief Executive Officer, are a part of our proxy solicitation materials.

This Notice of 2019 Annual Meeting and Proxy Statement and a proxy or voting instruction card are being mailed or made available to shareholders starting on or about March 14, 2019.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 25, 2019

This Notice of 2019 Annual Meeting and Proxy Statement and the 2018 Financial Report and Corporate and Shareholder Information are available on our website at https://investors.pfizer.com/financials/annual-reports/default.aspx. Except as stated otherwise, information on our website is not considered part of this Proxy Statement.

Margaret M. Madden signature
Margaret M. Madden
Senior Vice President and Corporate Secretary, Chief Governance Counsel
March 14, 2019

   ...Previous
Continue...   
WARNING: JavaScript is disabled. CLICK HERE for help.
  • Go to previous page
  • Go to previous page
Page 5 of 147
  • Go to next page
  • Go to next page